Chronic lung disease in very low birthweight infants: A 5-year review

Journal of Paediatrics and Child Health

Volumn 33, Issue 2, 1997, Pages 102-106

  Yeo, C L ^a   Choo, S ^a   Ho, L Y ^a,b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b Department of Neonatology ^*

Author keywords

chronic lung disease; neurodevelopmental outcome; very low birthweight infants

Indexed keywords

CEREBRAL PALSY; CHILD; CHRONIC LUNG DISEASE; DISABILITY; DISEASE ASSOCIATION; HUMAN; HYALINE MEMBRANE DISEASE; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN INTENSIVE CARE; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SEPTICEMIA; SURVIVAL RATE; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

EID: 0030982154     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1997.tb01009.x     Document Type: Review

References (24)

1. Avery ME, Tooley WH, Keller JB et al. Is chronic lung disease in low birthweight infants preventable? A survey of eight centers. Pediatrics. 1987; 79: 26-30.
2. Ong WH, Ho NK. 2-year study of bronchopulmonary dysplasia in very low birthweight infants. J. Singapore Pediatr. Soc. 1994; 36: 85-8.
3. Yip YY, Tan KL, Bronchopulmonary dysplasia in very low birth weight infants. J. Pediatr. Child Health. 1991; 27: 34-8.
4. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular haemorrhage: A study of infants with birthweights less than 1500 gm. J. Pediatr. 1978; 92: 529-34.
5. The Committee for the Classification of Retinopathy of Prematurity. An interventional classification retinopathy of prematurity. Arch. Ophthalmol. 1984; 102: 1130-4.
6. Bayley N. Bayley Scales of Infants Development. Psychological Corporation, New York, 1969.
7. American Psychiatric Association. Diagnostic and Statistics Manual of Mental Disorders. 3rd edn (revised). American Psychiatric Association, Washington, DC: 1987; 22-3.
8. Ford GW, Richards A, Kitchen WH, Lissenden V, Keith CG, Ryan WH. Handicap and Health Problems in 2 years old children of birth weight 500-1500 g. Aust. Pediatr. J. 1984; 21: 15-22.
9. Norusis MJ. SPSS-X: User's Guide. 2nd ed. Chicago: SPSS Inc., 1986.
10. Markestad T, Fitzhardinge PM. Growth and development in children recovering from bronchopulmonary dysplasia. J. Pediatr. 1979; 96: 597-602.
11. Shankaran S, Szego E, Eizert D, Siegel P. Severe bronchopulmonary dysplasia: Predictors of survival and outcome. Chest. 1984; 86: 607-10.
12. Mayes L, Perkett E, Stahlam MT. Severe bronchopulmonary dysplasia: A retrospective review. Acta Paediatr. Scand. 1983; 72: 225-9.
13. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy for hyaline membrane disease. N. Engl. J. Med. 1967; 276: 357-68.
14. Skidmore MD, Rivers A, Hack M. Increased risk of cerebral palsy among very low birthweight infants with chronic lung disease. Dev. Med. Child. Neurol. 1990; 32: 325-32.
15. Rhodes PG, Graves GR, Patel OM et al. Minimizing pneumothorax and bronchopulmonary dysplasia in ventilated infants with hyaline membrane disease. J. Pediatr. 1983; 103: 634-7.
16. Clark DA, Pincus LG, Oliphant M et al. HLA-A2 and chronic lung disease in neonates. JAMA. 1982; 248: 1868-9.
17. Frank L, Autor AP, Roberts RJ. Oxygen therapy and hyaline membrane disease: the effect of hyperoxia on pulmonary superoxide dismutase activity and the mediating role of plasma or serum. J. Pediatr. 1977; 90: 105-10.
18. Rojas MA, Gonzalez A, Bancalari E, Claure N, Pool C, Silva-Neto G. Changing trends in epidemiology and pathogenesis of neonatal chronic lung disease. J. Pediatr. 1995; 126: 605-10.
19. Cotton RB, Stahlam MT, Bender HW et al. Randomised trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J. Pediatr. 1978; 93: 647-51.
20. Merritt TA, Harris JP, Roghmann K et al. Early closure of patent ductus arteriosus in very low birth weight infants: A controlled trial. J. Pediatr. 1981; 99: 281-6.
21. Brown ER. Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. J. Pediatr. 1979; 95: 865-6.
22. Salzer NR, Salzer-Muhur U, Pollak A, Weninger M. Sepsis and indomethacin failure in premature infants with symptomatic ductus arteriosus. Lancet. 1987; 1: 977 [Letter].
23. Teberg AJ Pena I, Finella K, Aguilan T, Hodgman JE, Prediction of Neurodevelopmental outcome in infants with and without bronchopulmonary dysplasia. Am. J. Med. Sci. 1991; 301: 369-74.
24. Gray PH, Burns YR, Mohay HA, O'Callaghan MJ, Tudehope DI. Neurodevelopmental outcome of preterm infants with bronchopulmonary dysplasia. Arch. Dis. Child. 1995 73: F128-34.